Magnetic compression anastomosis is effective in treating stenosis after esophageal cancer surgery: a case report.

Colon interposition Complete stenosis after esophageal cancer surgery Esophageal cancer Magnetic compression anastomosis

Journal

Surgical case reports
ISSN: 2198-7793
Titre abrégé: Surg Case Rep
Pays: Germany
ID NLM: 101662125

Informations de publication

Date de publication:
17 Aug 2020
Historique:
received: 19 05 2020
accepted: 04 08 2020
entrez: 18 8 2020
pubmed: 18 8 2020
medline: 18 8 2020
Statut: epublish

Résumé

Esophagostomy is important in the treatment of esophageal cancer. However, esophagectomy has a higher risk of postoperative complications. Treatment for complications is often difficult, and in some cases, oral intake is no longer possible. Recently, magnetic compression anastomosis (MCA) was developed; it is a relatively safe method of anastomosis that does not require surgery in patients with stricture, obstruction, or dehiscence of the anastomosis after surgery. The patient was a 76-year-old Japanese man. He underwent esophagectomy with a three-field dissection for esophageal cancer. A cervical esophagostomy and chest drainage were performed for necrosis of the gastric tube. Following infection control, colon interposition was performed. However, after the operation, the colon necrotized and formed an abscess. Drainage controlled the infection, but the colon was completely obstructed. The patient was referred to our hospital to restore oral ingestion. Contrast studies showed that the length of the occlusion was 10 mm. The reconstruction was examined; reanastomosis by surgery was judged to be a high risk, so the strategy of anastomosis by MCA was adopted. In the operation, the anterior chest was opened to expose the colon, and a magnet was inserted directly into the blind end of the colon. The magnet was guided to the blind end of the esophagus using an oral endoscope. Two weeks after MCA, a contrast study confirmed the passage of the contrast agent from the esophagus to the colon. The patient eventually took 18 bougies after the MCA. However, since then, he has not needed a bougie. As of 1 year and 8 months after the MCA, the patient is living at home with oral intake restored. MCA is an effective and safe treatment for complete stenosis after esophageal cancer surgery.

Sections du résumé

BACKGROUND BACKGROUND
Esophagostomy is important in the treatment of esophageal cancer. However, esophagectomy has a higher risk of postoperative complications. Treatment for complications is often difficult, and in some cases, oral intake is no longer possible. Recently, magnetic compression anastomosis (MCA) was developed; it is a relatively safe method of anastomosis that does not require surgery in patients with stricture, obstruction, or dehiscence of the anastomosis after surgery.
CASE PRESENTATION METHODS
The patient was a 76-year-old Japanese man. He underwent esophagectomy with a three-field dissection for esophageal cancer. A cervical esophagostomy and chest drainage were performed for necrosis of the gastric tube. Following infection control, colon interposition was performed. However, after the operation, the colon necrotized and formed an abscess. Drainage controlled the infection, but the colon was completely obstructed. The patient was referred to our hospital to restore oral ingestion. Contrast studies showed that the length of the occlusion was 10 mm. The reconstruction was examined; reanastomosis by surgery was judged to be a high risk, so the strategy of anastomosis by MCA was adopted. In the operation, the anterior chest was opened to expose the colon, and a magnet was inserted directly into the blind end of the colon. The magnet was guided to the blind end of the esophagus using an oral endoscope. Two weeks after MCA, a contrast study confirmed the passage of the contrast agent from the esophagus to the colon. The patient eventually took 18 bougies after the MCA. However, since then, he has not needed a bougie. As of 1 year and 8 months after the MCA, the patient is living at home with oral intake restored.
CONCLUSIONS CONCLUSIONS
MCA is an effective and safe treatment for complete stenosis after esophageal cancer surgery.

Identifiants

pubmed: 32804348
doi: 10.1186/s40792-020-00974-y
pii: 10.1186/s40792-020-00974-y
pmc: PMC7431484
doi:

Types de publication

Journal Article

Langues

eng

Pagination

213

Références

Surg Case Rep. 2018 Aug 15;4(1):95
pubmed: 30112678
J Clin Oncol. 2012 Feb 1;30(4):413-8
pubmed: 22215745
J Thorac Dis. 2016 Apr;8(Suppl 4):S387-98
pubmed: 27195136
J Thorac Cardiovasc Surg. 2014 Mar;147(3):909-14
pubmed: 24332098
J Surg Oncol. 2016 Feb;113(2):159-64
pubmed: 26699417
Surg Case Rep. 2017 Dec;3(1):73
pubmed: 28547740
Esophagus. 2018 Jul;15(3):127-152
pubmed: 29948477
Gastrointest Endosc. 2010 Sep;72(3):530-5
pubmed: 20656288
J Clin Oncol. 2012 May 10;30(14):1615-9
pubmed: 22473157
J Hepatobiliary Pancreat Sci. 2011 May;18(3):357-65
pubmed: 21127913
Endoscopy. 2005 Apr;37(4):313-7
pubmed: 15824939
J Gastroenterol Hepatol. 2019 Mar;34(3):589-594
pubmed: 30278106
J Surg Oncol. 2014 Oct;110(5):599-610
pubmed: 25146593
Gut Liver. 2010 Sep;4 Suppl 1:S96-8
pubmed: 21103303
Ann Thorac Surg. 2014 Nov;98(5):1713-9; discussion 1719-20
pubmed: 25258155
Gastroenterology Res. 2019 Oct;12(5):267-270
pubmed: 31636778

Auteurs

Tetsuro Isozaki (T)

Department of Frontier Surgery Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan. t.isozaki@chiba-u.jp.

Kentaro Murakami (K)

Department of Frontier Surgery Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan.

Eigoro Yamanouchi (E)

Department of Radiology, International University of Health and Welfare Hospital, 537-3 Iguchi, Nasushiobara-shi, Tochigi, 329-2763, Japan.

Masaya Uesato (M)

Department of Frontier Surgery Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan.

Takeshi Toyozumi (T)

Department of Frontier Surgery Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan.

Yoshio Koide (Y)

Department of Surgery, Yarita Hospital, 899 Goi, Ichihara-shi, Chiba, 290-0056, Japan.

Soichiro Tsukamoto (S)

Department of Surgery, Yarita Hospital, 899 Goi, Ichihara-shi, Chiba, 290-0056, Japan.

Haruhito Sakata (H)

Department of Frontier Surgery Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan.

Koichi Hayano (K)

Department of Frontier Surgery Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan.

Masayuki Kano (M)

Department of Frontier Surgery Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan.

Hideki Hayashi (H)

Department of Frontier Surgery Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan.

Hisahiro Matsubara (H)

Department of Frontier Surgery Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan.

Classifications MeSH